Clinical Profile and Therapy of Hepatocelluar Carcinoma at a Tertiary Care Institute from South India: A Retrospective Study of 182 Patients
Journal Title: Indian Journal of Cancer Education and Research - Year 2017, Vol 5, Issue 1
Abstract
Objective: To study the clinical profile and therapy of hepatocellular carcinoma (HCC) at a tertiary care institute in Andhrapradesh, Southindia. Methods: Data analysis of HCC patients enrolled in between 2000 and 2015. HCC was diagnosed according to EASL criteria-USG/CT/MRI of the abdomen and/or serum alpha-fetoprotein and/or histology (where indicated). Barcelona Clinic Liver Cancer (BCLC) staging was done. Results: We registered 182 HCC patients [males 162 (89%), mean age 57.5 ± 12.1 years]. An “Early Peak” (17%) was detected in 28-40 yr age group. The etiology of HCC was: Hepatitis B virus 70 (35.7%), Hepatitis C virus 05 (2.74%). Serum -fetoprotein was >500 ng/ml in 43.8% and very high (>5000-100 000) in 30.6%. Classical features on triple phase CT in 80% with an average tumor size of (7.3 ± 2.1 cm), Portal vein invasion was seen in 40% and distant metastases in 11%. Majority of the patients (79.6%) were BCLC stage C and D. Biochemical: Thrombocytopenia (60%), anaemia in 30%, and 80% had an elevated alkaline phosphatase levels. Therapy was offered to 127 (69.78%) patients.Treatment given was as follows: Surgical resection (n=36 19.78%); Chemotherapy, both oral and iv (n=91 19.78%), and Sorafenib (n=36 19.78%), Best supportive care (n=55 30.22%), but survival data was not available due to lack of adequate followup. Conclusions: Hepatitis B infection is the predominant cause for HCC. Diagnostic range serum -fetoprotein was detected in only 43.8% of study patients but its level correlates well with the disease burden, outcome. An “Early Peak” was observed in 28-40 year age group. Majority of the patients present with advanced disease, precluding the curative therapies. Universal immunization with hepatitis B vaccination will reduce the HBV infection rates & in part HCC burden in near future.
Authors and Affiliations
Venkatesh M.
Keywords
Related Articles
- EP ID EP459821
- DOI 10.21088/ijcer.2321.9815.5117.5
- Views 85
- Downloads 0
Response to Induction Chemotherapy Predicts Survival in AML: A Single Centre Experience from North India
Aim: The present study was carried out to analyze the various patient related (e.g. age, sex, performance status), disease related (white blood cell count, cytogenetic and molecular mutational status)and treatment relat...
Comparison of Different Phenotypic Tests for Detection of ESBL (Extended Spectrum Beta Lactamases) Producing Pseudomonas Aeruginosa
Background: P. aeruginosa is the most common nosocomial pathogen encountered and a known organism causing high mortality and morbidity. Due to indiscriminate antibiotic use, resistance is very commonly known in them and...
Induction Chemotherapy in Unresectable or Locally Advanced Head and Neck Squamous Cell Cancer: A Single Center Retrospective Experience
Head and Neck Squamous Cell Carcinoma (HNSCC), have an unsatisfactory prognosis despite intensive local treatment. Single institution retrospective study of 60 patients, who were treated with induction chemotherapy follo...
Colorectal Cancer Incidence in Tertiary Health Care Centre-Hyderabad
Background: Colorectal cancer (CRC) is the fourth most common cancer in the world. Its incidence varies worldwide being high in western countries and in older age group and low in developing countries. Though relatively...
Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India
Background: Acute myeloid leukemia is a heterogenous clonal disorder of hematopoietic progenitor cells with different molecular genetic abnormalities, clinical characteristics and variable outcomes with currently availab...